Press Release on Q4 & Year ended FY 2026 for Audited Financial Results
RESULTS
▲ Positive Development
MEDIUM RISK
📅 Filed on BSE: 02 Jun 2026, 12:22 PM IST · BSE ID: eb537b1f-a0e4-4773-bb22-9c69b8bd0148
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's full-year profit more than doubled, driven by higher sales, despite a minor dip in Q4 revenue.
🤖 AI Summary
- Wanbury Ltd reported a 116.6% YoY increase in PAT to ₹66.1 Cr for FY26.
- FY26 EPS more than doubled to ₹20.55, up 122% from ₹9.32 in FY25.
- Revenue from operations grew by 8.5% YoY to ₹650.3 Cr for the full year FY26.
- EBITDA for FY26 stood at ₹107.7 Cr, a 34.9% YoY increase, with EBITDA margin at 16.5%.
- Q4 FY26 revenue declined 4.3% YoY to ₹164.6 Cr, impacted by the West Asia crisis in March 2026.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Revenue from Operations FY26
₹650.3 Cr
+8.5%
EBITDA FY26
₹107.7 Cr
+34.9%
EBITDA Margin FY26
16.5%
+330 bps
PAT FY26
₹66.1 Cr
+116.6%
PAT Margin FY26
10.2%
+509 bps
Revenue Q4 FY26
₹164.6 Cr
-4.3%
EBITDA Q4 FY26
₹30.1 Cr
-4.5%
PAT Q4 FY26
₹21.7 Cr
+7.2%
PAT Margin Q4 FY26
13.2%
+150 bps YoY
🏢 How This Affects the Company
The launch of a new Anaesthetic API with commercial dispatches to Europe beginning February 2026, and a pipeline of upcoming specialty APIs, strengthens the company's product portfolio and global API presence.
Full year FY26 PAT increased by 116.6% to ₹66.1 Cr and EPS more than doubled to ₹20.55, indicating improved profitability and shareholder value per share. The EBITDA margin expanded by 330 bps to 16.5% for FY26.
Completion of CAPEX at the Tanuku facility for the new Anaesthetic API and ongoing investments in debottlenecking and process optimization enhance capacity and operating leverage. Zero-observation regulatory clearances from MFDS Korea, USFDA, and ANVISA Brazil validate compliance systems.
The Q4 FY26 revenue decline due to the West Asia crisis highlights a sensitivity to geopolitical events impacting API export dispatches, particularly for a largely export-led business.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this financial results filing.
👤
Who Is Affected
Shareholders are affected by the company's increased profitability, as reflected in the more than doubling of EPS from ₹9.32 to ₹20.55 in FY26.
🔍
Management Signal
Management is signaling a focus on strengthening business fundamentals, operational efficiencies, and expansion of both API and formulations portfolios for future growth.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q1 FY27 results — monitor if revenue recovers from Q4 dip.
Updates on new API launches and pipeline progression.
Further details on formulations business turnaround strategy.
MEDIUM RISK
Geopolitical events can impact export-led revenue, as seen in Q4 FY26 with the West Asia crisis.
💡 Investor Takeaway
Wanbury Ltd's FY26 PAT surged 116.6% YoY to ₹66.1 Cr, with EPS doubling to ₹20.55. Revenue from operations increased 8.5% YoY to ₹650.3 Cr. Q4 FY26 revenue declined 4.3% YoY to ₹164.6 Cr, attributed to the West Asia crisis.
⚖️ Strengths & Concerns
✅ Positives
- FY26 PAT surged 116.6% YoY to ₹66.1 Cr, with PAT margin expanding 509 bps to 10.2%, reflecting strong bottom-line growth.
- EBITDA grew 34.9% YoY to ₹107.7 Cr in FY26, driven by revenue growth, favorable product mix, better yields, and procurement efficiencies.
⚠️ Concerns
- Q4 FY26 revenue declined 4.3% YoY to ₹164.6 Cr, impacted by disruptions to API export dispatches in March 2026 due to the West Asia crisis.
- Q4 FY26 EBITDA also saw a 4.5% YoY decline to ₹30.1 Cr, although EBITDA margin improved by 14 bps YoY to 18.2%.
❓ Frequently Asked Questions
What was Wanbury Ltd's PAT for the full year FY26?
Wanbury Ltd reported a Profit After Tax (PAT) of ₹66.1 Cr for the full year FY26, representing a 116.6% YoY growth from ₹30.5 Cr in FY25.
How much did Wanbury Ltd's EPS grow in FY26?
Wanbury Ltd's Earnings Per Share (EPS) more than doubled to ₹20.55 in FY26, marking a 122% increase from ₹9.32 in FY25.
What was Wanbury Ltd's revenue from operations in Q4 FY26?
Revenue from operations for Wanbury Ltd in Q4 FY26 stood at ₹164.6 Cr, which was a 4.3% YoY decline compared to ₹172.0 Cr in Q4 FY25.
What was the reason for the Q4 FY26 revenue decline for Wanbury Ltd?
The Q4 FY26 revenue decline was attributed to the West Asia crisis in late February, which disrupted API export dispatches during March 2026.
What was Wanbury Ltd's EBITDA for FY26?
Wanbury Ltd's EBITDA for FY26 was ₹107.7 Cr, an increase of 34.9% YoY from ₹79.8 Cr in FY25. The EBITDA margin was 16.5%.
Questions based on this BSE filing only. For information purposes.